Approval · Notice of Compliance 23865 · 2020
ADVIL COLD & FLU: Notice of Compliance 23865
Issued June 24, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23865
- Date
- June 24, 2020
- Company
- Glaxosmithkline Consumer Healthcare UlcMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL COLD & FLU | Not yet assigned | — |
| ADVIL PAIN & HEAD COLD NIGHT | Not yet assigned | — |
Medicinal ingredients
- DIPHENHYDRAMINE CITRATE 38 MG per TAB
- IBUPROFEN 200 MG per TAB